Market Overview:
The global postoperative pain therapeutics service market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic pain, rising geriatric population, and growing demand for better postoperative care. The global postoperative pain therapeutics service market is segmented on the basis of type into opioids, NSAIDs, local anesthetics, tricyclic antidepressants (TCAs), antiepileptic drugs (AEDs), and other drugs. The opioids segment is expected to dominate the market during the forecast period owing to their high efficacy in managing moderate-to-severe acute pain. However, NSAIDs are anticipated to grow at a higher CAGR due their lower risk for adverse effects as compared with opioids and other analgesics. On the basis of application, hospitals pharmacies accounted for majority share of the global postoperative pain therapeutics service market in 2017; however, retail pharmacies are projected to grow at a higher rate during 2018–2030 owing increased demand from consumers for over-the-counter medications for managing milder forms of acute pain after surgery.
Product Definition:
Postoperative pain therapeutics service is a service that helps patients manage their postoperative pain. This service can include anything from medications to therapies to educational resources. The importance of this service is that it can help patients recover more quickly and comfortably from surgery.
Opioids:
Postoperative pain is a major clinical problem that affects patient recovery and thus, the long-term outcome. Opioids are one of the most commonly used medications for postoperative pain management. The global opioids market is expected to grow at a significant rate over the forecast period owing to increasing prevalence of chronic diseases such as cancer, diabetes, and other autoimmune disorders that cause severe pain; this in turn will lead to an increase in demand for opioids over the forecast period.
NSAIDS:
NSAIDS (Non-steroidal Anti-inflammatory drugs) are the group of drugs that reduces inflammation by decreasing prostaglandins and leukotrienes. They are used as postoperative pain therapeutics to control acute and chronic pain. Some of the commercially available products in this category are aspirin, ibuprofen, naproxen sodium, diclofenac potassium, and others.
Application Insights:
The others application segment held the largest share of over 30.0% in 2017. The other applications include benzodiazepines, antidepressants, anticonvulsants, anti-inflammatory drugs, and local anesthetics among others. Benzodiazepines are widely used postoperative pain therapeutics as they provide effective analgesia without causing sedation or amnesia; these drugs are preferred for patients at risk of developing postoperative anxiety attacks or those who require a high level of consciousness during surgery (anesthesia).
Antidepressants hold immense potential in the treatment of chronic pain due to their ability to reduce neuropathic and nociceptive pains along with mental health conditions such as depression and anxiety disorders. This is expected to drive their consumption owing to increasing prevalence rates for these disorders globally coupled with growing awareness about the benefits associated with them among healthcare professionals and patients across the globe.
Regional Analysis:
North America dominated the global postoperative pain therapeutics service market in 2017. The presence of well-established healthcare infrastructure, high per capita income, and rising awareness among patients are some factors responsible for its large share. Moreover, government initiatives to control the increasing number of opioid prescriptions are expected to play a key role in this region’s growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare facilities and growing patient awareness regarding various treatment options available for postsurgical pain management. Furthermore, an increase in medical tourism due to affordable treatments is also expected fuel regional demand during the forecast period. ‰˜˜˜˜˜™‰™‰™‰¬© 2018 Novar Pharmacal Inc.
Growth Factors:
- Increasing incidence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%, and it is projected to increase to 30% by 2030. This will create a large pool of patients who will require postoperative pain management services.
- Growing demand for minimally invasive surgeries: Minimally invasive surgeries are becoming increasingly popular due to their many benefits, such as shorter hospital stays, reduced blood loss and surgical trauma, and faster recovery times. This is driving the demand for postoperative pain therapies and services.
- Advances in technology: Technological advances are enabling the development of novel postoperative pain therapies that are more effective and have fewer side effects than traditional treatments. This is contributing to the growth of the market for postoperative pain therapeutics services.
- Rising awareness about postoperative care: There has been a growing awareness among patients about the importance of proper postoperative care in order to reduce the risk of developing chronicpain after surgery .This is leading more people to seek out professional help for managing theirpost-surgicalpain .This trend will continue in future, boostingthe growthof this market segment.. 5) Growth in geriatric population: The global geriatric population (aged 65 years or older) is expectedto grow from 617 millionin 2015to 1billionby 2050 .The elderlyaremore likelythan younger individuals torequirepost-surgicalpain managementservicesdue touniquehealth concernsand increased vulnerabilityt
Scope Of The Report
Report Attributes
Report Details
Report Title
Postoperative Pain Therapeutics Service Market Research Report
By Type
Opioids, NSAIDS, Local Anesthetics, Tricyclic Antidepressants, Antiepileptic Drugs, Other
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Companies
Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly & Company, Bayer AG, Novartis AG, Camarus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Postoperative Pain Therapeutics Service Market Report Segments:
The global Postoperative Pain Therapeutics Service market is segmented on the basis of:
Types
Opioids, NSAIDS, Local Anesthetics, Tricyclic Antidepressants, Antiepileptic Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt Pharmaceuticals
- Trevena, Inc.
- Heron Therapeutics
- Pacira BioSciences, Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly & Company
- Bayer AG
- Novartis AG
- Camarus
Highlights of The Postoperative Pain Therapeutics Service Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Opioids
- NSAIDS
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
- Other
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postoperative Pain Therapeutics Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Postoperative Pain Therapeutics Service is a service that provides pharmacological and non-pharmacological interventions to manage postoperative pain.
Some of the major players in the postoperative pain therapeutics service market are Mallinckrodt Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Pacira BioSciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly & Company, Bayer AG, Novartis AG, Camarus.
The postoperative pain therapeutics service market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Postoperative Pain Therapeutics Service Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Postoperative Pain Therapeutics Service Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Postoperative Pain Therapeutics Service Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Postoperative Pain Therapeutics Service Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Postoperative Pain Therapeutics Service Market Size & Forecast, 2018-2028 4.5.1 Postoperative Pain Therapeutics Service Market Size and Y-o-Y Growth 4.5.2 Postoperative Pain Therapeutics Service Market Absolute $ Opportunity
Chapter 5 Global Postoperative Pain Therapeutics Service Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Postoperative Pain Therapeutics Service Market Size Forecast by Type
5.2.1 Opioids
5.2.2 NSAIDS
5.2.3 Local Anesthetics
5.2.4 Tricyclic Antidepressants
5.2.5 Antiepileptic Drugs
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Postoperative Pain Therapeutics Service Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Postoperative Pain Therapeutics Service Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Postoperative Pain Therapeutics Service Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Postoperative Pain Therapeutics Service Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Postoperative Pain Therapeutics Service Analysis and Forecast
9.1 Introduction
9.2 North America Postoperative Pain Therapeutics Service Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Postoperative Pain Therapeutics Service Market Size Forecast by Type
9.6.1 Opioids
9.6.2 NSAIDS
9.6.3 Local Anesthetics
9.6.4 Tricyclic Antidepressants
9.6.5 Antiepileptic Drugs
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Postoperative Pain Therapeutics Service Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Postoperative Pain Therapeutics Service Analysis and Forecast
10.1 Introduction
10.2 Europe Postoperative Pain Therapeutics Service Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Postoperative Pain Therapeutics Service Market Size Forecast by Type
10.6.1 Opioids
10.6.2 NSAIDS
10.6.3 Local Anesthetics
10.6.4 Tricyclic Antidepressants
10.6.5 Antiepileptic Drugs
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Postoperative Pain Therapeutics Service Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Postoperative Pain Therapeutics Service Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Postoperative Pain Therapeutics Service Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Postoperative Pain Therapeutics Service Market Size Forecast by Type
11.6.1 Opioids
11.6.2 NSAIDS
11.6.3 Local Anesthetics
11.6.4 Tricyclic Antidepressants
11.6.5 Antiepileptic Drugs
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Postoperative Pain Therapeutics Service Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Postoperative Pain Therapeutics Service Analysis and Forecast
12.1 Introduction
12.2 Latin America Postoperative Pain Therapeutics Service Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Postoperative Pain Therapeutics Service Market Size Forecast by Type
12.6.1 Opioids
12.6.2 NSAIDS
12.6.3 Local Anesthetics
12.6.4 Tricyclic Antidepressants
12.6.5 Antiepileptic Drugs
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Postoperative Pain Therapeutics Service Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Postoperative Pain Therapeutics Service Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Postoperative Pain Therapeutics Service Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Postoperative Pain Therapeutics Service Market Size Forecast by Type
13.6.1 Opioids
13.6.2 NSAIDS
13.6.3 Local Anesthetics
13.6.4 Tricyclic Antidepressants
13.6.5 Antiepileptic Drugs
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Postoperative Pain Therapeutics Service Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Postoperative Pain Therapeutics Service Market: Competitive Dashboard
14.2 Global Postoperative Pain Therapeutics Service Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mallinckrodt Pharmaceuticals
14.3.2 Trevena, Inc.
14.3.3 Heron Therapeutics
14.3.4 Pacira BioSciences, Inc.
14.3.5 Pfizer, Inc.
14.3.6 Teva Pharmaceutical Industries Ltd.
14.3.7 Eli Lilly & Company
14.3.8 Bayer AG
14.3.9 Novartis AG
14.3.10 Camarus